APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Selected research

Market Analysis & Forecast

Global Insulin Market Analysis and Forecast 2026-2032

Report ID 17400345022 January 2026193 pages

Choose your research edition.

Industry ResearchInsulin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.

This report presents an overview of global market for Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Insulin, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Insulin sales, projected growth trends, production technology, application and end-user industry.

Insulin Segment by Company

Novo Nordisk

Eli Lilly

Sanofi-Aventis

Tonghua Dongbao

Ganlee

United Laboratory

Jiangsu Wanbang

Insulin Segment by Type

Animal Insulin

Regular Human Insulin

Insulin Analogue

Insulin Segment by Application

Short Acting

Intermediate Acting

Long Acting

Pre-Mix Insulin

Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Animal Insulin Major Manufacturers Table 3. Regular Human Insulin Major Manufacturers Table 4. Insulin Analogue Major Manufacturers Table 5. Global Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Short Acting Major Manufacturers Table 7. Intermediate Acting Major Manufacturers Table 8. Long Acting Major Manufacturers Table 9. Pre-Mix Insulin Major Manufacturers Table 10. Insulin Industry Trends Table 11. Insulin Industry Drivers Table 12. Insulin Industry Opportunities and Challenges Table 13. Insulin Industry Restraints Table 14. Global Insulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Insulin Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Insulin Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Insulin Revenue Market Share by Region (2021-2026) Table 18. Global Insulin Revenue Market Share by Region (2027-2032) Table 19. Global Insulin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 20. Global Insulin Sales by Region (2021-2026) & (M Pcs) Table 21. Global Insulin Sales by Region (2027-2032) & (M Pcs) Table 22. Global Insulin Sales Market Share by Region (2021-2026) Table 23. Global Insulin Sales Market Share by Region (2027-2032) Table 24. Global Insulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Insulin Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Insulin Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Insulin Sales Market Share by Manufacturers (2021-2026) Table 28. Global Insulin Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 29. Global Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Insulin Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Insulin Manufacturers, Product Type & Application Table 32. Global Insulin Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Insulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Insulin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Insulin Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Insulin Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Insulin Revenue Market Share by Type (2021-2026) Table 39. Global Insulin Revenue Market Share by Type (2027-2032) Table 40. Global Insulin Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 41. Global Insulin Sales by Type (2021-2026) & (M Pcs) Table 42. Global Insulin Sales by Type (2027-2032) & (M Pcs) Table 43. Global Insulin Sales Market Share by Type (2021-2026) Table 44. Global Insulin Sales Market Share by Type (2027-2032) Table 45. Global Insulin Price by Type (2021-2026) & (US$/Pcs) Table 46. Global Insulin Price by Type (2027-2032) & (US$/Pcs) Table 47. Global Insulin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Insulin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Insulin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Insulin Revenue Market Share by Application (2021-2026) Table 51. Global Insulin Revenue Market Share by Application (2027-2032) Table 52. Global Insulin Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 53. Global Insulin Sales by Application (2021-2026) & (M Pcs) Table 54. Global Insulin Sales by Application (2027-2032) & (M Pcs) Table 55. Global Insulin Sales Market Share by Application (2021-2026) Table 56. Global Insulin Sales Market Share by Application (2027-2032) Table 57. Global Insulin Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Insulin Price by Application (2027-2032) & (US$/Pcs) Table 59. Novo Nordisk Company Information Table 60. Novo Nordisk Business Overview Table 61. Novo Nordisk Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 62. Novo Nordisk Insulin Product Portfolio Table 63. Novo Nordisk Recent Development Table 64. Eli Lilly Company Information Table 65. Eli Lilly Business Overview Table 66. Eli Lilly Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Eli Lilly Insulin Product Portfolio Table 68. Eli Lilly Recent Development Table 69. Sanofi-Aventis Company Information Table 70. Sanofi-Aventis Business Overview Table 71. Sanofi-Aventis Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Sanofi-Aventis Insulin Product Portfolio Table 73. Sanofi-Aventis Recent Development Table 74. Tonghua Dongbao Company Information Table 75. Tonghua Dongbao Business Overview Table 76. Tonghua Dongbao Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Tonghua Dongbao Insulin Product Portfolio Table 78. Tonghua Dongbao Recent Development Table 79. Ganlee Company Information Table 80. Ganlee Business Overview Table 81. Ganlee Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Ganlee Insulin Product Portfolio Table 83. Ganlee Recent Development Table 84. United Laboratory Company Information Table 85. United Laboratory Business Overview Table 86. United Laboratory Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. United Laboratory Insulin Product Portfolio Table 88. United Laboratory Recent Development Table 89. Jiangsu Wanbang Company Information Table 90. Jiangsu Wanbang Business Overview Table 91. Jiangsu Wanbang Insulin Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Jiangsu Wanbang Insulin Product Portfolio Table 93. Jiangsu Wanbang Recent Development Table 94. North America Insulin Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Insulin Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Insulin Sales by Type (2021-2026) & (M Pcs) Table 97. North America Insulin Sales by Type (2027-2032) & (M Pcs) Table 98. North America Insulin Sales Price by Type (2021-2026) & (US$/Pcs) Table 99. North America Insulin Sales Price by Type (2027-2032) & (US$/Pcs) Table 100. North America Insulin Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Insulin Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Insulin Sales by Application (2021-2026) & (M Pcs) Table 103. North America Insulin Sales by Application (2027-2032) & (M Pcs) Table 104. North America Insulin Sales Price by Application (2021-2026) & (US$/Pcs) Table 105. North America Insulin Sales Price by Application (2027-2032) & (US$/Pcs) Table 106. North America Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Insulin Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 110. North America Insulin Sales by Country (2021-2026) & (M Pcs) Table 111. North America Insulin Sales by Country (2027-2032) & (M Pcs) Table 112. North America Insulin Sales Price by Country (2021-2026) & (US$/Pcs) Table 113. North America Insulin Sales Price by Country (2027-2032) & (US$/Pcs) Table 114. United States Insulin Revenue (2021-2032) & (US$ Million) Table 115. Canada Insulin Revenue (2021-2032) & (US$ Million) Table 116. Mexico Insulin Revenue (2021-2032) & (US$ Million) Table 117. Europe Insulin Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Insulin Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Insulin Sales by Type (2021-2026) & (M Pcs) Table 120. Europe Insulin Sales by Type (2027-2032) & (M Pcs) Table 121. Europe Insulin Sales Price by Type (2021-2026) & (US$/Pcs) Table 122. Europe Insulin Sales Price by Type (2027-2032) & (US$/Pcs) Table 123. Europe Insulin Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Insulin Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Insulin Sales by Application (2021-2026) & (M Pcs) Table 126. Europe Insulin Sales by Application (2027-2032) & (M Pcs) Table 127. Europe Insulin Sales Price by Application (2021-2026) & (US$/Pcs) Table 128. Europe Insulin Sales Price by Application (2027-2032) & (US$/Pcs) Table 129. Europe Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Insulin Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 133. Europe Insulin Sales by Country (2021-2026) & (M Pcs) Table 134. Europe Insulin Sales by Country (2027-2032) & (M Pcs) Table 135. Europe Insulin Sales Price by Country (2021-2026) & (US$/Pcs) Table 136. Europe Insulin Sales Price by Country (2027-2032) & (US$/Pcs) Table 137. Germany Insulin Revenue (2021-2032) & (US$ Million) Table 138. France Insulin Revenue (2021-2032) & (US$ Million) Table 139. U.K. Insulin Revenue (2021-2032) & (US$ Million) Table 140. Italy Insulin Revenue (2021-2032) & (US$ Million) Table 141. Russia Insulin Revenue (2021-2032) & (US$ Million) Table 142. Spain Insulin Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Insulin Revenue (2021-2032) & (US$ Million) Table 144. Switzerland Insulin Revenue (2021-2032) & (US$ Million) Table 145. Sweden Insulin Revenue (2021-2032) & (US$ Million) Table 146. Poland Insulin Revenue (2021-2032) & (US$ Million) Table 147. China Insulin Revenue by Type (2021-2026) & (US$ Million) Table 148. China Insulin Revenue by Type (2027-2032) & (US$ Million) Table 149. China Insulin Sales by Type (2021-2026) & (M Pcs) Table 150. China Insulin Sales by Type (2027-2032) & (M Pcs) Table 151. China Insulin Sales Price by Type (2021-2026) & (US$/Pcs) Table 152. China Insulin Sales Price by Type (2027-2032) & (US$/Pcs) Table 153. China Insulin Revenue by Application (2021-2026) & (US$ Million) Table 154. China Insulin Revenue by Application (2027-2032) & (US$ Million) Table 155. China Insulin Sales by Application (2021-2026) & (M Pcs) Table 156. China Insulin Sales by Application (2027-2032) & (M Pcs) Table 157. China Insulin Sales Price by Application (2021-2026) & (US$/Pcs) Table 158. China Insulin Sales Price by Application (2027-2032) & (US$/Pcs) Table 159. Asia Insulin Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Insulin Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Insulin Sales by Type (2021-2026) & (M Pcs) Table 162. Asia Insulin Sales by Type (2027-2032) & (M Pcs) Table 163. Asia Insulin Sales Price by Type (2021-2026) & (US$/Pcs) Table 164. Asia Insulin Sales Price by Type (2027-2032) & (US$/Pcs) Table 165. Asia Insulin Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Insulin Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Insulin Sales by Application (2021-2026) & (M Pcs) Table 168. Asia Insulin Sales by Application (2027-2032) & (M Pcs) Table 169. Asia Insulin Sales Price by Application (2021-2026) & (US$/Pcs) Table 170. Asia Insulin Sales Price by Application (2027-2032) & (US$/Pcs) Table 171. Asia Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Insulin Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 175. Asia Insulin Sales by Country (2021-2026) & (M Pcs) Table 176. Asia Insulin Sales by Country (2027-2032) & (M Pcs) Table 177. Asia Insulin Sales Price by Country (2021-2026) & (US$/Pcs) Table 178. Asia Insulin Sales Price by Country (2027-2032) & (US$/Pcs) Table 179. Japan Insulin Revenue (2021-2032) & (US$ Million) Table 180. South Korea Insulin Revenue (2021-2032) & (US$ Million) Table 181. India Insulin Revenue (2021-2032) & (US$ Million) Table 182. Australia Insulin Revenue (2021-2032) & (US$ Million) Table 183. Taiwan Insulin Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Insulin Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Insulin Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Insulin Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Insulin Sales by Type (2021-2026) & (M Pcs) Table 188. SAMEA Insulin Sales by Type (2027-2032) & (M Pcs) Table 189. SAMEA Insulin Sales Price by Type (2021-2026) & (US$/Pcs) Table 190. SAMEA Insulin Sales Price by Type (2027-2032) & (US$/Pcs) Table 191. SAMEA Insulin Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Insulin Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Insulin Sales by Application (2021-2026) & (M Pcs) Table 194. SAMEA Insulin Sales by Application (2027-2032) & (M Pcs) Table 195. SAMEA Insulin Sales Price by Application (2021-2026) & (US$/Pcs) Table 196. SAMEA Insulin Sales Price by Application (2027-2032) & (US$/Pcs) Table 197. SAMEA Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Insulin Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 201. SAMEA Insulin Sales by Country (2021-2026) & (M Pcs) Table 202. SAMEA Insulin Sales by Country (2027-2032) & (M Pcs) Table 203. SAMEA Insulin Sales Price by Country (2021-2026) & (US$/Pcs) Table 204. SAMEA Insulin Sales Price by Country (2027-2032) & (US$/Pcs) Table 205. Brazil Insulin Revenue (2021-2032) & (US$ Million) Table 206. Argentina Insulin Revenue (2021-2032) & (US$ Million) Table 207. Chile Insulin Revenue (2021-2032) & (US$ Million) Table 208. Colombia Insulin Revenue (2021-2032) & (US$ Million) Table 209. Peru Insulin Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Insulin Revenue (2021-2032) & (US$ Million) Table 211. Israel Insulin Revenue (2021-2032) & (US$ Million) Table 212. UAE Insulin Revenue (2021-2032) & (US$ Million) Table 213. Turkey Insulin Revenue (2021-2032) & (US$ Million) Table 214. Iran Insulin Revenue (2021-2032) & (US$ Million) Table 215. Egypt Insulin Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Insulin Distributors List Table 219. Insulin Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Insulin Image Figure 2. Global Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Animal Insulin Image Figure 5. Regular Human Insulin Image Figure 6. Insulin Analogue Image Figure 7. Global Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Short Acting Image Figure 10. Intermediate Acting Image Figure 11. Long Acting Image Figure 12. Pre-Mix Insulin Image Figure 13. Global Insulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Insulin Revenue (2021-2032) & (US$ Million) Figure 15. Global Insulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Insulin Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Insulin Revenue Market Share by Region (2021-2032) Figure 18. Global Insulin Sales (2021-2032) & (M Pcs) Figure 19. Global Insulin Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 20. Global Insulin Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Insulin Sales YoY (2021-2032) & (M Pcs) Figure 22. Europe Insulin Sales YoY (2021-2032) & (M Pcs) Figure 23. China Insulin Sales YoY (2021-2032) & (M Pcs) Figure 24. Asia (Excluding China) Insulin Sales YoY (2021-2032) & (M Pcs) Figure 25. South America, Middle East and Africa Insulin Sales YoY (2021-2032) & (M Pcs) Figure 26. Global Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Insulin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Insulin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Insulin Revenue Market Share by Type (2021-2032) Figure 32. Global Insulin Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 33. Global Insulin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Insulin Sales Market Share by Type (2021-2032) Figure 35. Global Insulin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Insulin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Insulin Revenue Market Share by Application (2021-2032) Figure 38. Global Insulin Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 39. Global Insulin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Insulin Sales Market Share by Application (2021-2032) Figure 41. North America Insulin Revenue Share by Type (2021-2032) Figure 42. North America Insulin Sales Share by Type (2021-2032) Figure 43. North America Insulin Revenue Share by Application (2021-2032) Figure 44. North America Insulin Sales Share by Application (2021-2032) Figure 45. North America Insulin Revenue Share by Country (2021-2032) Figure 46. North America Insulin Sales Share by Country (2021-2032) Figure 47. Europe Insulin Revenue Share by Type (2021-2032) Figure 48. Europe Insulin Sales Share by Type (2021-2032) Figure 49. Europe Insulin Revenue Share by Application (2021-2032) Figure 50. Europe Insulin Sales Share by Application (2021-2032) Figure 51. Europe Insulin Revenue Share by Country (2021-2032) Figure 52. Europe Insulin Sales Share by Country (2021-2032) Figure 53. China Insulin Revenue Share by Type (2021-2032) Figure 54. China Insulin Sales Share by Type (2021-2032) Figure 55. China Insulin Revenue Share by Application (2021-2032) Figure 56. China Insulin Sales Share by Application (2021-2032) Figure 57. Asia Insulin Revenue Share by Type (2021-2032) Figure 58. Asia Insulin Sales Share by Type (2021-2032) Figure 59. Asia Insulin Revenue Share by Application (2021-2032) Figure 60. Asia Insulin Sales Share by Application (2021-2032) Figure 61. Asia Insulin Revenue Share by Country (2021-2032) Figure 62. Asia Insulin Sales Share by Country (2021-2032) Figure 63. SAMEA Insulin Revenue Share by Type (2021-2032) Figure 64. SAMEA Insulin Sales Share by Type (2021-2032) Figure 65. SAMEA Insulin Revenue Share by Application (2021-2032) Figure 66. SAMEA Insulin Sales Share by Application (2021-2032) Figure 67. SAMEA Insulin Revenue Share by Country (2021-2032) Figure 68. SAMEA Insulin Sales Share by Country (2021-2032) Figure 69. Insulin Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Insulin Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Animal Insulin
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Sanofi-Aventis
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Jiangsu Wanbang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Insulin Market by Type
  3. 1.2.1 Global Insulin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Animal Insulin
  5. 1.2.3 Regular Human Insulin
  6. 1.2.4 Insulin Analogue
  7. 1.3 Insulin Market by Application
  8. 1.3.1 Global Insulin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Short Acting
  10. 1.3.3 Intermediate Acting
  11. 1.3.4 Long Acting
  12. 1.3.5 Pre-Mix Insulin
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Insulin Market Dynamics
  1. 2.1 Insulin Industry Trends
  2. 2.2 Insulin Industry Drivers
  3. 2.3 Insulin Industry Opportunities and Challenges
  4. 2.4 Insulin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Insulin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Insulin Revenue by Region
  3. 3.2.1 Global Insulin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Insulin Revenue by Region (2021-2026)
  5. 3.2.3 Global Insulin Revenue by Region (2027-2032)
  6. 3.2.4 Global Insulin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Insulin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Insulin Sales by Region
  9. 3.4.1 Global Insulin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Insulin Sales by Region (2021-2026)
  11. 3.4.3 Global Insulin Sales by Region (2027-2032)
  12. 3.4.4 Global Insulin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Insulin Revenue by Manufacturers
  2. 4.1.1 Global Insulin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Insulin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Insulin Sales by Manufacturers
  6. 4.2.1 Global Insulin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Insulin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Insulin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Insulin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Insulin Manufacturers, Product Type & Application
  13. 4.7 Global Insulin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Insulin Market CR5 and HHI
  16. 4.8.2 2025 Insulin Tier 1, Tier 2, and Tier 3
5 Insulin Market by Type
  1. 5.1 Global Insulin Revenue by Type
  2. 5.1.1 Global Insulin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Insulin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Insulin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Insulin Sales by Type
  6. 5.2.1 Global Insulin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Sales by Type (2021-2032) & (M Pcs)
  8. 5.2.3 Global Insulin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Insulin Price by Type
6 Insulin Market by Application
  1. 6.1 Global Insulin Revenue by Application
  2. 6.1.1 Global Insulin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Insulin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Insulin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Insulin Sales by Application
  6. 6.2.1 Global Insulin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Insulin Sales by Application (2021-2032) & (M Pcs)
  8. 6.2.3 Global Insulin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Insulin Price by Application
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Insulin Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Insulin Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Sanofi-Aventis
  14. 7.3.1 Sanofi-Aventis Company Information
  15. 7.3.2 Sanofi-Aventis Business Overview
  16. 7.3.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi-Aventis Insulin Product Portfolio
  18. 7.3.5 Sanofi-Aventis Recent Developments
  19. 7.4 Tonghua Dongbao
  20. 7.4.1 Tonghua Dongbao Company Information
  21. 7.4.2 Tonghua Dongbao Business Overview
  22. 7.4.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tonghua Dongbao Insulin Product Portfolio
  24. 7.4.5 Tonghua Dongbao Recent Developments
  25. 7.5 Ganlee
  26. 7.5.1 Ganlee Company Information
  27. 7.5.2 Ganlee Business Overview
  28. 7.5.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ganlee Insulin Product Portfolio
  30. 7.5.5 Ganlee Recent Developments
  31. 7.6 United Laboratory
  32. 7.6.1 United Laboratory Company Information
  33. 7.6.2 United Laboratory Business Overview
  34. 7.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 United Laboratory Insulin Product Portfolio
  36. 7.6.5 United Laboratory Recent Developments
  37. 7.7 Jiangsu Wanbang
  38. 7.7.1 Jiangsu Wanbang Company Information
  39. 7.7.2 Jiangsu Wanbang Business Overview
  40. 7.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jiangsu Wanbang Insulin Product Portfolio
  42. 7.7.5 Jiangsu Wanbang Recent Developments
8 North America
  1. 8.1 North America Insulin Market Size by Type
  2. 8.1.1 North America Insulin Revenue by Type (2021-2032)
  3. 8.1.2 North America Insulin Sales by Type (2021-2032)
  4. 8.1.3 North America Insulin Price by Type (2021-2032)
  5. 8.2 North America Insulin Market Size by Application
  6. 8.2.1 North America Insulin Revenue by Application (2021-2032)
  7. 8.2.2 North America Insulin Sales by Application (2021-2032)
  8. 8.2.3 North America Insulin Price by Application (2021-2032)
  9. 8.3 North America Insulin Market Size by Country
  10. 8.3.1 North America Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Insulin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Insulin Market Size by Type
  2. 9.1.1 Europe Insulin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Insulin Sales by Type (2021-2032)
  4. 9.1.3 Europe Insulin Price by Type (2021-2032)
  5. 9.2 Europe Insulin Market Size by Application
  6. 9.2.1 Europe Insulin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Insulin Sales by Application (2021-2032)
  8. 9.2.3 Europe Insulin Price by Application (2021-2032)
  9. 9.3 Europe Insulin Market Size by Country
  10. 9.3.1 Europe Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Insulin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Insulin Market Size by Type
  2. 10.1.1 China Insulin Revenue by Type (2021-2032)
  3. 10.1.2 China Insulin Sales by Type (2021-2032)
  4. 10.1.3 China Insulin Price by Type (2021-2032)
  5. 10.2 China Insulin Market Size by Application
  6. 10.2.1 China Insulin Revenue by Application (2021-2032)
  7. 10.2.2 China Insulin Sales by Application (2021-2032)
  8. 10.2.3 China Insulin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Insulin Market Size by Type
  2. 11.1.1 Asia Insulin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Insulin Sales by Type (2021-2032)
  4. 11.1.3 Asia Insulin Price by Type (2021-2032)
  5. 11.2 Asia Insulin Market Size by Application
  6. 11.2.1 Asia Insulin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Insulin Sales by Application (2021-2032)
  8. 11.2.3 Asia Insulin Price by Application (2021-2032)
  9. 11.3 Asia Insulin Market Size by Country
  10. 11.3.1 Asia Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Insulin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Insulin Market Size by Type
  2. 12.1.1 SAMEA Insulin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Insulin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Insulin Price by Type (2021-2032)
  5. 12.2 SAMEA Insulin Market Size by Application
  6. 12.2.1 SAMEA Insulin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Insulin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Insulin Price by Application (2021-2032)
  9. 12.3 SAMEA Insulin Market Size by Country
  10. 12.3.1 SAMEA Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Insulin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Insulin Value Chain Analysis
  2. 13.1.1 Insulin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Insulin Production Mode & Process
  6. 13.2 Insulin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Insulin Distributors
  9. 13.2.3 Insulin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst